Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CEMIPLIMAB-RWLC Cause Multiple organ dysfunction syndrome? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Multiple organ dysfunction syndrome have been filed in association with CEMIPLIMAB-RWLC. This represents 0.5% of all adverse event reports for CEMIPLIMAB-RWLC.

7
Reports of Multiple organ dysfunction syndrome with CEMIPLIMAB-RWLC
0.5%
of all CEMIPLIMAB-RWLC reports
6
Deaths
4
Hospitalizations

How Dangerous Is Multiple organ dysfunction syndrome From CEMIPLIMAB-RWLC?

Of the 7 reports, 6 (85.7%) resulted in death, 4 (57.1%) required hospitalization, and 1 (14.3%) were considered life-threatening.

Is Multiple organ dysfunction syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CEMIPLIMAB-RWLC. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does CEMIPLIMAB-RWLC Cause?

Death (128) Disease progression (101) Fatigue (71) Off label use (68) Rash (64) Dyspnoea (55) Pyrexia (52) Pruritus (44) Asthenia (42) Diarrhoea (42)

What Other Drugs Cause Multiple organ dysfunction syndrome?

TACROLIMUS (1,847) CYCLOPHOSPHAMIDE (1,597) MYCOPHENOLATE MOFETIL (1,566) PREDNISONE (1,525) DEXAMETHASONE (1,355) METHOTREXATE (1,317) METHYLPREDNISOLONE (1,278) RITUXIMAB (1,188) PREDNISOLONE (1,154) CYCLOSPORINE (933)

Which CEMIPLIMAB-RWLC Alternatives Have Lower Multiple organ dysfunction syndrome Risk?

CEMIPLIMAB-RWLC vs CENEGERMIN-BKBJ CEMIPLIMAB-RWLC vs CENOBAMATE CEMIPLIMAB-RWLC vs CEPHALEXIN CEMIPLIMAB-RWLC vs CERITINIB CEMIPLIMAB-RWLC vs CERLIPONASE ALFA

Related Pages

CEMIPLIMAB-RWLC Full Profile All Multiple organ dysfunction syndrome Reports All Drugs Causing Multiple organ dysfunction syndrome CEMIPLIMAB-RWLC Demographics